UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010050 |
|---|---|
| Receipt number | R000011768 |
| Scientific Title | Phase Ia/Ib multicenter investigator initiated trial of Mogamulizumab for advanced or recurrent cancer. |
| Date of disclosure of the study information | 2013/02/15 |
| Last modified on | 2017/02/20 10:39:14 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/02/15 14:02:24 | ||
| 2 | Update | 2013/02/15 14:22:42 | Recruitment status |
|
| 3 | Update | 2013/09/03 16:16:54 | Email |
|
| 4 | Update | 2014/02/26 11:13:57 | Key exclusion criteria Key exclusion criteria |
|
| 5 | Update | 2014/09/17 14:37:07 | Homepage URL |
|
| 6 | Update | 2015/03/04 09:46:10 | Last follow-up date |
|
| 7 | Update | 2015/05/26 12:50:58 | Recruitment status Last follow-up date |
|
| 8 | Update | 2015/05/26 13:30:28 | Last follow-up date |
|
| 9 | Update | 2016/02/16 16:49:57 | Randomization unit |
|
| 10 | Update | 2016/02/16 16:59:04 | Last follow-up date |
|
| 11 | Update | 2016/08/23 11:14:14 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 12 | Update | 2017/02/20 10:39:14 | Recruitment status |
